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[8]-Gingerol is an active component of Zinger and shows several pharmacological activities, such as anti-
pyretic and anti-inﬂammation characteristics. To identify a potential skin-whitening agent, the inhibitory
effects of [8]-gingerol on melanogenesis and its mechanism of action were investigated. In the present
study, the effects of [8]-gingerol on mushroom tyrosinase, tyrosinase activity and melanin content were
determined spectrophotometrically; the expression of melanogenesis-related proteins in B16F10 and
B16F1 melanoma cells were determined by Western blotting. Furthermore, the possible signaling path-
ways involved in [8]-gingerol-mediated depigmentation were also investigated using speciﬁc inhibitors.
The results revealed that [8]-gingerol (5–100 lM) effectively suppressed intracellular tyrosinase activity
and decreased the amount of melanin in B16F10 and B16F1 cells. In addition, [8]-gingerol also effectively
decreased intracellular reactive species (RS) and reactive oxygen species (ROS) levels at the same dose
range. Our results indicated that [8]-gingerol inhibited melanogenesis in B16F10 and B16F1 cells by
down-regulation of both mitogen-activated protein kinases (MAPK) and protein kinase A (PKA) signaling
pathways or through its antioxidant properties. Hence, [8]-gingerol could be used as an effective skin-
whitening agent.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license. 1. Introduction
Melanin is responsible for skin color and plays an important
role in protecting the skin against ultraviolet light injury. It has
been reported that overproduction and accumulation of melanin
causes several skin disorders, including melasma, freckles, age
spots and other hyperpigmentation syndromes [1]. Tyrosinase is
the rate-limiting enzyme in the ﬁrst two steps of melanogenesis
in which L-tyrosine is hydroxylated to L-DOPA (L-dihydroxyphenyl-
alanine), and L-DOPA is further oxidized into the corresponding o-
quinone [2]. Moreover, the microphthalmia-associated transcrip-
tion factors (MITF) and other enzymes, such as tyrosinase related
protein-1 (TRP-1) and tyrosinase related protein-2 (TRP-2), have
been reported to contribute to the production of melanin [3–5].
The melanocortin 1 receptor (MC1R) also plays an important role
in MSH-induced pigmentation [6]. Recently, inhibitors ofmelanogenesis have been increasingly applied in skin care prod-
ucts for the treatment or prevention of abnormal hyperpigmenta-
tion [7]. Furthermore, it is reported that melanogenesis produces
hydrogen peroxide (H2O2) and other ROS and RS, which lead to
the generation of high-grade oxidative stress in melanocytes.
Hence, free radical scavengers play an important role in the regu-
lation of melanogenesis. It has been established that ROS scaveng-
ers and inhibitors of ROS generation may inhibit UV-induced
melanogenesis [8]. Therefore, antioxidants or compounds with re-
dox properties could also be used to inhibit or delay hyperpigmen-
tation [2]. Furthermore, antioxidants such as ascorbic derivatives
and reduced glutathione (GSH) have been applied as inhibitory
agents of melanogenesis [9,10].
It has been reported that numerous phenolic compounds show
antioxidant activity, and many naturally occurring inhibitors of
melanogenesis contain a phenol structure [11–13]. We recently re-
ported that [6]-gingerol inhibited melanin synthesis in B16F10
melanoma cells through the activation of the PI3K signaling path-
way [14]. Another active phenolic ingredient of Zingiber ofﬁcinale
roscope (Zingiberaceae), [8]-gingerol (Fig. 1A), is reported to pos-
sess various pharmacological activities, including immunosuppres-
sive activity [15], cardiotonic effects [16] and anti-inﬂammatory
capacities [17]. However, the inhibitory action of [8]-gingerol on
melanogenesis has never been explored. In the present study, we
Fig. 1. The inhibitory effects of [8]-gingerol on melanogenesis. (A) The chemical structure of [8]-gingerol. (B) The effects of [8]-gingerol on mushroom tyrosinase activity. (C)
The effects of [8]-gingerol on melanin content in B16F10 and B16F1 cells. (D) The effects of [8]-gingerol on tyrosinase activity in B16F10 and B16F1 cells. The results are
presented as percentages of the control, and the data are presented as the mean ± S.D. of three separate experiments. The values are signiﬁcantly different compared with the
control. ⁄p < 0.05.
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tyrosinase activity, the expression of melanogenesis-related pro-
teins, and melanin content in B16F10 and B16F1 melanoma cells.
Moreover, we examined the inhibitory effect and associated anti-
oxidant property of [8]-gingerol on melanogenesis by assessing
its free radical scavenging activities. Furthermore, to examine the
possible signaling pathways involving [8]-gingerol, we also studied
the changes of MAPKs and protein kinase A (PKA) signaling inhib-
ited by [8]-gingerol.
2. Materials and methods
2.1. Chemicals and reagents
The [8]-gingerol was purchased from WAKO (Japan). The anti-
bodies were from Santa Cruz Biotech (Santa Cruz, CA, USA), and
the ECL reagent was from Millipore (MA, USA). Protein kinase reg-
ulators, including 3-isobutyl-1-methyl-xanthine (IBMX), SB203580
(p38 MAPK-inhibitor), SP600125 (c-Jun N-terminal kinase inhibi-
tor; JNK inhibitor) and PD98059 (MEK 1/2-inhibitor) were from To-
cris (Ellisville, Missouri, USA). All of the other chemical reagents
were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Cell culture
The B16F10 cells (ATCC CRL-6475, BCRC60031) and B16F1 cells
(ATCC CRL-6323, BCRC60030) were obtained from the Bioresource
Collection and Research Center (BCRC), Taiwan. The B16F10, B16F1
and HaCaT cells [18] were maintained in DMEM (Hyclone, Logan,
UT) supplemented with 10% fetal bovine serum and 1% antibiotics
at 37 C, 5% CO2 in a humidiﬁed incubator.2.3. Cell viability assay
The assay was performed using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) [19]. The cells were ex-
posed to various concentrations of [8]-gingerol for 24 h, and the
MTT solution was then added to the wells. The insoluble derivative
of MTT produced by intracellular dehydrogenase was solubilized
with ethanol–DMSO (1:1 mixture solution). The absorbance of
the wells at 570 nm was read using a microplate reader.2.4. Assay of mushroom tyrosinase activity
The enzyme inhibition experiments were conducted as previ-
ously described [20]. Brieﬂy, 10 lL of the aqueous solution of
mushroom tyrosinase (200 units) was added to a 96-well micro-
plate, for a total volume of a 200 lL mixture containing 5 mM L-
DOPA, which was dissolved in 50 mM phosphate buffered saline
(PBS) (pH 6.8). The assay mixture was incubated at 37 C for
30 min and the absorbance of dopachrome was measured at
490 nm.2.5. Measurement of melanin content
The intracellular melanin content was measured as described
by Tsuboi et al. [21]. The cells were treated with a-MSH
(100 nM) for 24 h, and the melanin content was then determined
after treatment with either [8]-gingerol (5–100 lM) or arbutin
(2 mM) for additional 24 h. After treatment, the cell pellets con-
taining a known number of cells were solubilized in 1 N NaOH at
60 C for 60 min. The melanin content was assayed at 405 nm.
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The cellular tyrosinase activity was determined as described
previously [22]. The cells were treated with a-MSH (100 nM) for
24 h and then with [8]-gingerol (5–100 lM) or arbutin (2 mM)
for 24 h. After treatments, the cell extracts (100 lL) were mixed
with freshly prepared L-DOPA solution (0.1% in PBS) and incubated
at 37 C, the absorbance at 490 nm was measured.2.7. Western blotting assay
The cells were treated with [8]-gingerol (5–100 lM) or kojic
acid (200 lM), lysed in PBS containing proteinase inhibitor at
4 C for 20 min. Proteins (50 lg) were resolved by SDS–polyacryl-
amide gel electrophoresis and electrophoretically transferred to a
polyvinylidene ﬂuoride (PVDF) ﬁlter. The nylon ﬁlter was blocked
for 1 h in 5% fat-free milk in PBST buffer (PBS with 0.05% Tween-
20). After a brief wash, the ﬁlter was incubated overnight at 4 C
with several antibodies; these antibodies included anti-MITF
(1:1000), anti-TRP1 (1:6000), anti-TRP2 (1:1000), anti-MC1R
(1:500), anti-GAPDH (1:1500), anti-tyrosinase (1:2000), anti-
p-p38 (1:500), anti-p38 (1:500), anti-p-JNK (1:500), anti-JNK
(1:500), anti-p-ERK (1:500), anti-ERK (1:500), anti-p-CERB
(1:500), and anti-CERB (1:200). Following incubation, the ﬁlter
was extensively washed in PBST buffer. Subsequent incubation
with goat anti-mouse antibody (1:10,000) conjugated with horse-
radish peroxidase was conducted at room temperature for 2 h. The
blot was visualized using an ECL reagent. The relative amounts of
expressed proteins compared to total GAPDH were analyzed using
Multi Gauge 3.0 software (Fuji, Tokyo).2.8. Protein kinase regulators assay
The cells were treated with a-MSH (100 nM) for 24 h fol-
lowed by a 1 h addition of 10 lM of different protein kinase reg-
ulators, including IBMX, SB203580, SP600125 and PD98059.
After these treatments, 100 lM of [8]-gingerol and 10 lM of
the above kinase regulators were added to the cells and incu-
bated for an additional 23 h. The melanin contents were assayed
as described above.2.9. Determination of cellular ROS and RS level
The cells were cultured in 24-well plates and treated with [8]-
gingerol (5–100 lM) for 24 h. The cells were then incubated with
24 mMH2O2 at 37 C for 30 min. After incubation, 20,70-dichloroﬂu-
orescein diacetate (DCFH-DA) was added to the wells and cultured
for 30 min. The ﬂuorescence intensities of DCF were measured at
an excitation wavelength of 504 nm and an emission wavelength
of 524 nm [23] using a Fluoroskan Ascent ﬂuorescent reader (Ther-
mo Scientiﬁc, Vantaa, Finland). The data were analyzed using As-
cent software (Thermo Scientiﬁc, Vantaa, Finland). Reactive
species (RS) were evaluated in the culture supernatant [24].
Twenty-ﬁve millimolar of DCFH-DA was added to the incubation
media, and changes in ﬂuorescence were estimated at an excita-
tion wavelength of 486 nm and an emission wavelength of
530 nm for 30 min.2.10. Statistical analysis
Statistical analysis of the experimental data was performed
using the two-tailed t-test including the p-values. All of the differ-
ences were considered to be statistically signiﬁcant at p < 0.05.3. Results
3.1. Inhibitory effects of [8]-gingerol on melanogenesis
The results shown in Fig. 1B, reveal that the remaining mush-
room tyrosinase activity was 92.48 ± 4.55%, 86.34 ± 4.25%,
82.66 ± 1.95% and 82.54 ± 1.95% of the control for the 5, 25, 50
and 100 lM of [8]-gingerol treatments, respectively. In addition,
the tyrosinase activity was also inhibited by kojic acid
(200 lM), and the remaining enzyme activity was 47.06 ± 0.98%
of control (p < 0.05) (Fig. 1 B). Thus, [8]-gingerol may be an inhib-
itor of mushroom tyrosinase. The results in Fig. 1C, indicate that
[8]-gingerol signiﬁcantly decreased the melanin content in
B16F10 and B16F1 cells. After treatment, the melanin content in
B16F10 cells was 95.3 ± 0.74%, 88.11 ± 1.97%, 81.27 ± 0.94% and
66.74 ± 2.05% for the 5, 25, 50 and 100 lM [8]-gingerol
treatments, respectively. The remaining intracellular melanin
content was 77.35 ± 0.90% of the control for arbutin (2 mM)
(p < 0.05). Meanwhile, the melanin content in B16F1 cells was
98.02 ± 1.43%, 92.88 ± 2.08%, 88.26 ± 1.48% and 74.8 ± 2.15% for
the 5, 25, 50 and 100 lM [8]-gingerol treatments, respectively.
The remaining intracellular melanin content was 73.35 ± 1.25%
of the control for arbutin (2 mM) (p < 0.05). The results indicate
that 100 lM of [8]-gingerol has stronger effects than arbutin.
The remaining B16F10 intracellular tyrosinase activity was
81.19 ± 1.7%, 58.87 ± 3.77%, 51.7 ± 2.99% and 40.53 ± 1.55% for
the 5, 25, 50 and 100 lM of [8]-gingerol treatments, respectively.
The intracellular tyrosinase activity was 68.03 ± 2.4% after the
cells were treated with arbutin (2 mM) (p < 0.05). In addition,
the remaining B16F1 intracellular tyrosinase activity was
83.41 ± 0.85%, 67.96 ± 0.77%, 60.19 ± 0.39% and 50.92 ± 0.9% for
the 5, 25, 50 and 100 lM of [8]-gingerol treatments, respectively.
The intracellular tyrosinase activity was 73.45 ± 1.41% after the
cells were treated with arbutin (2 mM) (p < 0.05) (Fig. 1D). The
results indicate that [8]-gingerol exhibited a more potent inhibi-
tory effect on a-MSH-induced tyrosinase activity in B16F10 and
B16F1 cells than did arbutin.3.2. [8]-Gingerol inhibited melanogenesis-related protein expression in
B16F10 and B16F1 cells
The expression levels of melanogenesis-related proteins were
examined using Western blots (Fig. 2A and E). The results indicate
that 5–100 lM of [8]-gingerol treatment led to a signiﬁcantly re-
duced level of MC1R, and 100 lM of [8]-gingerol signiﬁcantly de-
creased the expression of TRP-2 (Fig. 2B and F). Furthermore, the
protein contents of MITF, TRP-1 and tyrosinase were slightly chan-
ged after [8]-gingerol treatment.3.3. [8]-Gingerol down-regulated the cAMP signaling pathway
The PKA signaling pathway is associated with regulating mela-
nogenesis. The impacts of [8]-gingerol on the expression and phos-
phorylation of CREB were examined using Western blots (Fig. 2C
and G). The results show that [8]-gingerol decreased the expres-
sion of p-CREB; the ratios of p-CREB/CREB in B16F10 cells were
1.13, 0.9, 0.88 and 0.87 for the 5, 25, 50 and 100 lM of [8]-gingerol
treatments, respectively (Fig. 2D). Also, the ratios of p-CREB/CREB
in B16F1 cells were 1.12, 0.92, 0.86 and 0.8 for the 5, 25, 50 and
100 lM of [8]-gingerol treatments, respectively (Fig. 2H). The
application of [8]-gingerol in IBMX-treated B16F10 cells signiﬁ-
cantly decreased the cellular melanin content. The results indicate
that cAMP-mediated PKA signaling was affected by [8]-gingerol
(Fig. 3A).
Fig. 2. The effect of [8]-gingerol on melanogenesis-related protein expression and signaling pathways. (A, C, E, G) Western blotting of B16F10 and B16F1 cells. (B, D, F, H) The
relative amounts of MITF, TRP-1, tyrosinase, TRP-2 and MC1R compared to the total GAPDH, or phosphorylated protein compared to un-phosphorylated protein were
calculated and analyzed using Multi Gauge 3.0 software, and the values represented the mean of triplicate experiments ± standard deviations. ⁄p < 0.05; ⁄⁄p < 0.01.
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Fig. 3. The effects of [8]-gingerol on melanin content in IBMX, SP600125, SB203580, PD98059-treated B16F10 cells. (A) The melanin content of IBMX-treated cells and
(IBMX+[8]-gingerol)-treated cells. (B) The melanin content of SP600125- and (SP600125 + [8]-gingerol)-treated cells. (C) The melanin content of SB203580- and
(SB203580 + [8]-gingerol)-treated cells. (D) The melanin content of PD98059-treated cells and (PD98059 + [8]-gingerol)-treated cells. The results are represented as
percentages of the control, and the data are presented as the mean ± S.D. of three separate experiments. The values are signiﬁcantly different compared with the control.
⁄p < 0.05; ⁄⁄p < 0.01.
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The JNK signaling pathway is involved in regulating melanogen-
esis. The results shown in Fig. 2C, reveal that [8]-gingerol de-
creased the expression of p-JNK; the ratios of p-JNK/JNK in
B16F10 cells were 0.89, 0.86, 0.71 and 0.54 for the 5, 25, 50 and
100 lM [8]-gingerol treatments, respectively (Fig. 2D). Besides,
the ratios of p-JNK/JNK in B16F1 cells were 0.94, 0.91, 0.8 and
0.65 for the 5, 25, 50 and 100 lM [8]-gingerol treatments, respec-
tively (Fig. 2H). The addition of [8]-gingerol to SP600125-treated
B16F10 cells signiﬁcantly decreased the cellular melanin content.
The results indicate that the JNK-mediated signaling pathway,
which is involved in melanin production, was affected by [8]-ging-
erol (Fig. 3B).3.5. [8]-Gingerol down-regulated p38 MAPK signaling pathway
To further investigate the role of p38 MAPK signaling on the [8]-
gingerol-induced anti-melanogenic effect, we employed a speciﬁc
inhibitor of p38, SB203580, which blocks p38 MAPK signaling.
The cells were pre-treated with 10 lM SB203580 in the presence
of 100 nM a-MSH and 5–100 lM of [8]-gingerol, and the melanin
content was then measured. As shown in Fig. 2C, various concen-
trations of [8]-gingerol decreased the expression p-p38; the ratiosof p-p38/p38 in B16F10 cells were 1.01, 0.69, 0.68 and 0.49 for the
5, 25, 50 and 100 lM of [8]-gingerol treatments, respectively
(Fig. 2D). The ratios of p-p38/p38 in B16F1 cells were 0.95, 0.86,
0.74 and 0.66 for the 5, 25, 50 and 100 lM of [8]-gingerol treat-
ments, respectively (Fig. 2H). The results in Fig. 3C, reveal that
the speciﬁc inhibitor of p38 MAPK, SB203580, attenuated a-
MSH-stimulated melanin synthesis. These results suggest that
[8]-gingerol inhibited melanin synthesis by down-regulating p38
MAPK signaling and, subsequently, decreased melanin synthesis
in a-MSH-stimulated B16F10 cells.
3.6. [8]-Gingerol down-regulated ERK-mediated signaling pathway
The ERK signaling pathway is involved in regulating melano-
genesis. The results shown in Fig. 2C, reveal that [8]-gingerol de-
creased the expression of p-ERK; the ratios of p-ERK/ERK in
B16F10 cells were 0.67, 0.66, 0.61 and 0.59 for the 5, 25, 50 and
100 lM of [8]-gingerol treatments, respectively (Fig. 2D). The ra-
tios of p-ERK/ERK in B16F1 cells were 0.93, 0.83, 0.76 and 0.72
for the 5, 25, 50 and 100 lM of [8]-gingerol treatments, respec-
tively (Fig. 2H). The addition of [8]-gingerol in PD98059-treated
B16F10 cells signiﬁcantly decreased the cellular melanin content.
The results indicate that the ERK-mediated signaling pathway is
involved in melanin production was affected by [8]-gingerol treat-
ment (Fig. 3D).
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B16F1 cells
In the ROS assay, [8]-gingerol signiﬁcantly depleted the intracel-
lular ROS content, and the remaining ROS levels in B16F10 cells
were 97.21 ± 0.95%, 91.04 ± 4.36%, 82 ± 3.35% and 71.01 ± 1.45%
for the 5, 25, 50 and 100 lM of [8]-gingerol treatments,
respectively. The ROS level for the positive standard Trolox
(2 mM) was 66.69 ± 1.68%. Simultaneously, the remaining ROS
levels in B16F1 cells were 99.11 ± 1.34%, 93.25 ± 3.27%,
86.53 ± 2.82% and 77.18 ± 2.54% for the 5, 25, 50 and 100 lM of
[8]-gingerol treatments, respectively. The ROS level for Trolox
(2 mM) was 70.42 ± 2.23% (Fig. 4A). Additionally, [8]-gingerol also
signiﬁcantly depleted B16F10 intracellular RS levels. The remaining
RS levels were 91.04 ± 0.79%, 83.61 ± 3.95%, 77.95 ± 1.87% and
74.96 ± 3.51% for the 5, 25, 50 and 100 lM of [8]-gingerol
treatments, respectively. The RS level for Trolox (0.2 mM) was
68.6 ± 0.8%. The remaining RS levels in B16F1 cells were
95.44 ± 1.48%, 90.67 ± 1.89%, 85.28 ± 2.37% and 80.39 ± 1.92% for
the 5, 25, 50 and 100 lM of [8]-gingerol treatments, respectively.
The RS level for Trolox (0.2 mM) was 75.54 ± 1.75% (Fig. 4B). The
results shown in Fig. 4 reveal that [8]-gingerol signiﬁcantly
suppressed intracellular ROS and RS production. Therefore,
[8]-gingerol was able to protect melanoma cells from oxidative in-
jury by depletion of ROS and RS generation andmay down-regulate
UV-induced melanogenesis.Fig. 4. The effect of [8]-gingerol on the RS and ROS content in B16F10 and B16F1
cells. (A) [8]-Gingerol decreased the cellular ROS level. (B) [8]-Gingerol depleted the
cellular RS content. The results are expressed as percentages of the control. The data
are presented as the mean ± S.D. ⁄p < 0.05.4. Discussion
In the cell viability assay, it is found that the tested concentra-
tions of [8]-gingerol (5, 25, 50 and 100 lM) showed no cytotoxicity
to the B16F10, B16F1 and HaCaT cells (data not shown). In the
present study, a-MSH was used as a cAMP inducer to stimulate
melanin synthesis. Evidence has shown that a-MSH can bind
MC1R and activate adenylate cyclase, which in turn catalyzes
ATP to cAMP and increases intracellular cAMP levels [25]. It has
also been reported that binding of the human MC1R by its ligands
can activate the cAMP signaling pathway and regulate pigmenta-
tion of human melanocytes [26].
In mammals, melanin biosynthesis is directly regulated by
three major enzymes, tyrosinase, TRP-1 and TRP-2 [27]. Further-
more, MITF is known to be the most important regulator of
melanocyte differentiation and pigmentation [28] and is the ma-
jor transcriptional regulator of the tyrosinase, TRP-1 and TRP-2
genes. The results shown in Fig. 2 indicate that [8]-gingerol
decreased the protein expression levels of those proteins and
inhibited tyrosinase activity, in turn decreasing the melanin
content in B16F10 cells. Fig. 2 indicates that [8]-gingerol de-
creased MC1R expression and further suggests that [8]-gingerol
inhibited melanogenesis induced via a-MSH-mediated intracellu-
lar cAMP up-regulation. Moreover, the results shown in Fig. 3
further conﬁrm that [8]-gingerol inhibited cAMP-mediated PKA
signaling.
The MAPK family comprises three types of protein kinases,
including extracellular responsive kinase (ERK), c-Jun N-terminal
kinase (JNK) and p38 MAPK. It has been reported that MAPKs
can act to modulate melanogenesis [29–31]. It has been reported
that p38 activation positively contributes to melanin production
[32] by activating the cAMP response element-binding protein
(CREB), and CREB activates MITF expression [33]. The results in
Fig. 3 provide evidence that [8]-gingerol could inactivate CREB,
JNK and p38, in turn inhibiting MITF expression (Fig. 2). Further-
more, it has been reported that protein kinase A (PKA) signaling is
involved in melanin production [34]. The elevation of cellular
cAMP levels could activate PKA. In turn, activated PKA canactivate CREB, leading to the activation of MITF transcriptional
activity and resulting in the expressions of melanogenesis-related
proteins. Our results shown in Fig. 3 also suggest that [8]-gingerol
inhibits melanin synthesis through blocking of the PKA
pathway.
The skin is exposed to UV radiation and environmental oxidiz-
ing pollutants and is a preferred target of oxidative stress. It has
been reported that ultraviolet irradiation induces the formation
of RS and ROS in cutaneous tissue, provoking toxic changes, such
as lipid peroxidation and enzyme inactivation [35]. To counteract
the oxidative damage, the skin is equipped with a network of enzy-
matic and non-enzymatic antioxidant systems. The results shown
in Fig. 4 suggest that the [8]-gingerol-induced decrease in melanin
production may be attributed to its depletion of cellular RS and
ROS.
This is the ﬁrst report regarding the effect of [8]-gingerol on
melanin production. In the present study, it was determined that
[8]-gingerol signiﬁcantly inhibits tyrosinase activity and decreases
melanin synthesis. Moreover, [8]-gingerol also expresses
intracellular free radical scavenging activity. The results suggest
that [8]-gingerol decreases melanin production, which may be
attributed to its inhibitory action upon the signaling pathway that
regulates tyrosinase activity or by the depletion of cellular RS and
ROS. Further, our results demonstrate that [8]-gingerol decreases
melanogenesis in melanoma cells by inactivating PKA and MAPK
signaling pathways, reducing MITF expression and inhibiting
tyrosinase activity. Additionally, the inhibitory effect of [8]-ginger-
ol on melanin production may also be mediated by the depletion of
the intracellular ROS and RS contents.
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